Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042.
Maas SLN, Sievers P, Weber DC, Weller M, van den Bent MJ, Mair MJ, Kros JM, Carparrotti F, von Deimling A, Salvador VF, Peerdeman SM, Casas-Martin J, Gorlia T, Sahm F, Preusser M. Maas SLN, et al. Among authors: mair mj. Acta Neuropathol. 2023 Dec;146(6):837-840. doi: 10.1007/s00401-023-02642-5. Epub 2023 Oct 19. Acta Neuropathol. 2023. PMID: 37855895 Free PMC article. No abstract available.
LAG-3 expression in the inflammatory microenvironment of glioma.
Mair MJ, Kiesel B, Feldmann K, Widhalm G, Dieckmann K, Wöhrer A, Müllauer L, Preusser M, Berghoff AS. Mair MJ, et al. J Neurooncol. 2021 May;152(3):533-539. doi: 10.1007/s11060-021-03721-x. Epub 2021 Mar 2. J Neurooncol. 2021. PMID: 33651248 Free PMC article.
Neurological complications of cancer immunotherapy.
Roth P, Winklhofer S, Müller AMS, Dummer R, Mair MJ, Gramatzki D, Le Rhun E, Manz MG, Weller M, Preusser M. Roth P, et al. Among authors: mair mj. Cancer Treat Rev. 2021 Jun;97:102189. doi: 10.1016/j.ctrv.2021.102189. Epub 2021 Mar 23. Cancer Treat Rev. 2021. PMID: 33872978 Free article. Review.
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville-Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balaná C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J, Pichler J, Bruna J, Ducray F, Reijneveld JC, Mawrin C, Bendszus M, Marosi C, Golfinopoulos V, Coens C, Gorlia T, Weller M, Sahm F, Wick W. Preusser M, et al. Among authors: mair mj. Neuro Oncol. 2022 May 4;24(5):755-767. doi: 10.1093/neuonc/noab243. Neuro Oncol. 2022. PMID: 34672349 Free PMC article. Clinical Trial.
Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns.
Mair MJ, Leibetseder A, Heller G, Puhr R, Tomasich E, Goldberger S, Hatziioannou T, Wöhrer A, Widhalm G, Dieckmann K, Aichholzer M, Weis S, von Oertzen T, Furtner J, Pichler J, Preusser M, Berghoff AS. Mair MJ, et al. Clin Cancer Res. 2022 Oct 14;28(20):4565-4573. doi: 10.1158/1078-0432.CCR-22-1133. Clin Cancer Res. 2022. PMID: 35998208
Emerging systemic treatment options in meningioma.
Mair MJ, Berghoff AS, Brastianos PK, Preusser M. Mair MJ, et al. J Neurooncol. 2023 Jan;161(2):245-258. doi: 10.1007/s11060-022-04148-8. Epub 2022 Oct 1. J Neurooncol. 2023. PMID: 36181606 Free PMC article. Review.
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M. Albert NL, et al. Among authors: mair mj. Lancet Oncol. 2024 Jan;25(1):e29-e41. doi: 10.1016/S1470-2045(23)00525-9. Lancet Oncol. 2024. PMID: 38181810 Review.
28 results